Login / Signup

A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis.

Guofang DengLiang Fu
Published in: The Lancet. Infectious diseases (2024)
Keyphrases
  • drug resistant
  • mycobacterium tuberculosis
  • multidrug resistant
  • acinetobacter baumannii
  • pulmonary tuberculosis
  • adverse drug
  • human immunodeficiency virus
  • electronic health record
  • antiretroviral therapy